Patents by Inventor Ami Sen

Ami Sen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
    Publication number: 20050214831
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers are provided.
    Type: Application
    Filed: February 4, 2005
    Publication date: September 29, 2005
    Applicant: MILLENNIUM PHARMACEUTICALS, INC.
    Inventors: John Monahan, Manjula Gannavarapu, Sebastian Hoersch, Shubhangi Kamatkar, Steven Kovats, Rachel Meyers, Michael Morrissey, Peter Olandt, Ami Sen, Petter Veiby, Gordon Mills, Robert Bast, Karen Lu, Rosemarie Schmandt, Xumei Zhao, Karen Glatt
  • Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
    Publication number: 20030087250
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers are provided.
    Type: Application
    Filed: March 14, 2002
    Publication date: May 8, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: John E. Monahan, Manjula Gannavarapu, Sebastian Hoersch, Shubhangi Kamatkar, Steven G. Kovats, Rachel E. Meyers, Michael P. Morrisey, Peter J. Olandt, Ami Sen, Petter Ole Veiby, Gordon B. Mills, Robert C. Bast, Karen Lu, Rosemarie E. Schmandt, Xumei Zhao, Karen Glatt
  • Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
    Publication number: 20030003479
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers. A variety of marker genes are provided, wherein changes in the levels of expression of one or more of the marker genes is correlated with the presence of ovarian cancer.
    Type: Application
    Filed: April 19, 2002
    Publication date: January 2, 2003
    Applicant: Millennium Pharmaceutical, Inc.
    Inventors: Steven G. Kovats, Ami Sen, Michael P. Morrissey, James Lillie